CFO TribuneCFO Voice ↗
More

Executive record

Tyler Zeronda

Tyler Zeronda holds the CFO seat at Yarrow Bioscience, Inc. on the record, Chief Financial Officer, effective July 27, 2026.

1 verified record · 1 company · current seat on the record: Yarrow Bioscience, Inc.

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-07-28TransitionYarrow Bioscience, Inc.current seat

    Yarrow Bioscience, Inc. CFO transition: Tyler Zeronda to succeed Mutya Harsch

    Named as the incoming officer, Chief Financial Officer

    effective July 27, 2026 · 8-K filed July 28, 2026 · sec.gov, Item 5.02

Companies

1

Yarrow Bioscience, Inc.VYNE

Pharmaceutical Preparations

This page lists only verified filing records that name Tyler Zeronda, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.